Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study
Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study
António Ferreira, Lia Bally, Marc Y. Donath, David Herzig et al.
Citations
1 citations
Journal
BMJ Open
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
1.29
article
Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study
António Ferreira, Lia Bally, Marc Y. Donath, David Herzig, Matthias Hepprich, Justus Fischer, Marco Cattaneo
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(5)
Institutions
University of Basel (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Department of Biomedicine Basel (CH), Kantonsschule Olten (CH)